Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singapore Paincare HoldingsSGX:FRQ 9-Day RSI is 36.71 as of Sep. 01, 2026. The stock has 5 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Singapore Paincare Holdings ranks better than 83.64% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SGX:FRQ's 9-Day RSI is ranked better than 83.64% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 49.67
vs SGX:FRQ: 36.71
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Singapore Paincare Holdings 9-Day RSI Related Terms
SGX:FRQ vs HCA, THC, EHC: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Singapore Paincare Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singapore Paincare Holdings 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Singapore Paincare Holdings's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Singapore Paincare Holdings's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Paincare Holdings (SGX:FRQ) has a 9-Day RSI of 36.71 as of Sep. 01, 2026. According to the industry distribution chart, Singapore Paincare Holdings ranks #114 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is Singapore Paincare Holdings' 9-Day RSI too high?
Singapore Paincare Holdings' current 9-Day RSI is 36.71. The Healthcare Providers & Services industry median 9-Day RSI is 49.67. Singapore Paincare Holdings' value of 36.71 is 26.1% below this industry median. Based on the distribution chart, Singapore Paincare Holdings ranks #114 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Singapore Paincare Holdings' 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Paincare Holdings ranks #114 out of 697 companies for 9-Day RSI. This places Singapore Paincare Holdings in the top 16% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 49.67. Singapore Paincare Holdings' value of 36.71 is 26.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 49.67, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Singapore Paincare Holdings's current 9-Day RSI of 36.71 is 26.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 49.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Paincare Holdings's current 9-Day RSI is 36.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Paincare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Singapore Paincare Holdings (SGX:FRQ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.17, compared to a current price of S$0.06 — trading 64.7% below its estimated fair value. The current 9-Day RSI is 36.71 and 26.1% below the Healthcare Providers & Services industry median of 49.67. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Singapore Paincare Holdings (SGX:FRQ), the current 9-Day RSI is 36.71 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, primary care, and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company operates mainly in Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:FRQ has been successfully added to your 
